Medicus Pharma Ltd.
MDCX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.51M | -35.75M | -17.09M | -14.55M | -11.16M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 111.70K | 111.70K | 111.70K | -- | -- |
| Total Other Non-Cash Items | 19.82M | 16.07M | 590.30K | 944.20K | 875.30K |
| Change in Net Operating Assets | 569.80K | 206.10K | 688.40K | 595.10K | 32.90K |
| Cash from Operations | -22.78M | -19.36M | -15.70M | -13.01M | -10.25M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.62M | -4.62M | -- | -- | -- |
| Cash from Investing | -4.62M | -4.62M | -- | -- | -- |
| Total Debt Issued | 11.87M | 11.87M | 4.50M | 5.17M | 5.17M |
| Total Debt Repaid | -7.39M | -5.64M | -- | -- | -- |
| Issuance of Common Stock | 28.25M | 21.83M | 12.82M | 11.30M | 7.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -790.20K | -721.10K | -352.40K | -25.00K | -- |
| Cash from Financing | 31.94M | 27.34M | 16.96M | 16.45M | 12.69M |
| Foreign Exchange rate Adjustments | -2.90K | -1.70K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.54M | 3.36M | 1.26M | 3.44M | 2.45M |